June Lee - 06 Jan 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
4
Filing time
10 Jan 2022, 15:15:26 UTC
Previous filing
22 Nov 2021
Next filing
02 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $0 +47,954 $0.000000 47,954 06 Jan 2022 Common Stock 47,954 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal annual installments over a three-year period measured from one year following January 11, 2022, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.